Anderson Cynthia Lynn 4
4 · Vistagen Therapeutics, Inc. · Filed Jun 25, 2025
Insider Transaction Report
Form 4
Anderson Cynthia Lynn
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2025-06-23+100,000→ 100,000 totalExercise: $1.96Exp: 2035-06-23→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the "Grant Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date.